Companies / SOLV vs WST
SOLV vs WST: Solventum and West Pharmaceutical Services
Solventum (SOLV) reported $8.3B in revenue against a 18.7% net margin, while West Pharmaceutical Services (WST) reported $3.1B at a 16.1% net margin, most recently.
| Metric | SOLV | WST |
|---|---|---|
| Revenue | $8.3B | $3.1B |
| Net Income | $1.6B | $0.5B |
| Gross Margin | 53.5% | 35.9% |
| Operating Margin | 26.2% | 19.0% |
| EPS (Diluted) | $8.88 | $6.79 |
| Free Cash Flow | $-10.0M | $0.5B |
| Total Debt | $5.0B | $0.2B |
| P/E Ratio | 8.9× | 40.5× |
| P/B Ratio | 2.7× | 6.2× |
| Stock Price | $87.11 | $392.32 |
| Fiscal year | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
| SOLV Revenue | $8.1B | $8.2B | $8.3B | $8.3B |
| WST Revenue | $2.9B | $2.9B | $2.9B | $3.1B |